Lumetry Diagnostics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Early Stage VC
- Investors
-
6
Lumetry Diagnostics General Information
Description
Developer of a breath gas analysis device designed to empower individuals with lung disease to monitor their respiratory health at home. The company offers a user-friendly capnometer combining hardware and software with AI algorithms and an intuitive app, enabling patients and healthcare providers to achieve greater self-control and timely intervention in managing their lung conditions.
Contact Information
Website
www.lumetry-diagnostics.comCorporate Office
- Nikolaiplatz 4
- Graz, 8020
- Austria
Corporate Office
- Nikolaiplatz 4
- Graz, 8020
- Austria
Lumetry Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 10-Nov-2026 | Completed | Startup | |||
| 1. Early Stage VC | 20-Mar-2023 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lumetry Diagnostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lumetry Diagnostics Patents
Lumetry Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4371481-A1 | Method and apparatus for determining arterial co2 concentration | Inactive | 21-Nov-2022 | ||
| EP-4622546-A1 | Method and apparatus for determining arterial co2 concentration | Pending | 21-Nov-2022 | ||
| US-20260182859-A1 | Method and apparatus for determining arterial co2 concentration | Pending | 21-Nov-2022 | ||
| WO-2024110413-A1 | Method and apparatus for determining arterial co2 concentration | Inactive | 21-Nov-2022 | A61B5/0836 |
Lumetry Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lumetry Diagnostics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Raiffeisenlandesbank Niederösterreich-Wien | PE/Buyout | Minority | ||
| ARAX Capital Partners | Venture Capital | Minority | ||
| aws Gründungsfonds | Venture Capital | Minority | ||
| CommuModo | Corporation | Minority | ||
| Keystone Investors | Hedge Fund | Minority |
Lumetry Diagnostics FAQs
-
When was Lumetry Diagnostics founded?
Lumetry Diagnostics was founded in 2022.
-
Where is Lumetry Diagnostics headquartered?
Lumetry Diagnostics is headquartered in Graz, Austria.
-
What is the size of Lumetry Diagnostics?
Lumetry Diagnostics has 14 total employees.
-
What industry is Lumetry Diagnostics in?
Lumetry Diagnostics’s primary industry is Monitoring Equipment.
-
Is Lumetry Diagnostics a private or public company?
Lumetry Diagnostics is a Private company.
-
What is Lumetry Diagnostics’s current revenue?
The current revenue for Lumetry Diagnostics is .
-
Who are Lumetry Diagnostics’s investors?
Raiffeisenlandesbank Niederösterreich-Wien, ARAX Capital Partners, aws Gründungsfonds, CommuModo, and Keystone Investors are 5 of 6 investors who have invested in Lumetry Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
